Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Pharm ; 660: 124298, 2024 Jul 20.
Artigo em Inglês | MEDLINE | ID: mdl-38825172

RESUMO

One of the most common forms of controlled release technology for oral drug delivery comprises an active ingredient dispersed in a hydrophilic matrix forming polymer such as hydroxypropyl methylcellulose (HPMC), which is tableted via direct compression. However, HPMC may pose problems in direct compression due to its poor flowability. Hence, mannitol syrup was spray-coated over fluidized HPMC particles to produce co-processed HPMC-mannitol at ratios of 20:80, 50:50, and 70:30. Particles of pure HPMC, co-processed HPMC-mannitol, and their respective physical mixtures were evaluated for powder flowability, compression profiles, and controlled release performance. It was found that co-processed HPMC-mannitol consisted of particles with improved flow compared to pure HPMC particles. Sufficiently strong tablets of >2 MPa could be produced at moderate to high compression forces of 150-200 MPa. The dissolution profile could be tuned to obtain desired release profiles by altering HPMC-mannitol ratios. Co-processed HPMC-mannitol offers an interesting addition to the formulator's toolbox in the design of controlled release formulations for direct compression.


Assuntos
Preparações de Ação Retardada , Liberação Controlada de Fármacos , Excipientes , Derivados da Hipromelose , Manitol , Comprimidos , Manitol/química , Derivados da Hipromelose/química , Excipientes/química , Preparações de Ação Retardada/química , Solubilidade , Composição de Medicamentos/métodos , Química Farmacêutica/métodos , Pós
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...